SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 14.00
-0.54 (-3.71%)
May 22, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 784.02 million as of May 22, 2026. Its market cap has decreased by -28.58% in one year.
Market Cap
784.02M
Enterprise Value
731.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 784.02M, an increase of 1,129.80%. That is a compound annual growth rate of 28.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 784.02M | -34.95% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.34B |
| Xspray Pharma AB | 1.17B |
| Medivir AB | 1.10B |
| Cantargia AB | 790.59M |
| Infant Bacterial Therapeutics AB | 749.01M |
| Oncopeptides AB | 719.42M |
| FluoGuide | 678.50M |
| Corline Biomedical AB | 475.62M |